Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spondin-1 | cis | Discovery | rs10832169 | 11:14,066,486 | A/G | 0.50 | 997 | -0.361 | 0.040 | 8.7×10-19 | -1.060 | 4.1×10-15 | 1.2×10-8 |
Spondin-1 | cis | Replication | rs10832169 | 11:14,066,486 | G/A | 0.47 | 337 | 0.340 | 0.056 | 2.7×10-9 | 1.080 | 1.3×10-8 | 3×10-9 |
Target (abbrv.) | Spondin-1 |
Target (full name) | Spondin-1 |
Somalogic ID (Sequence ID) | SL005115 (4297-62_3) |
Entrez Gene Symbol | SPON1 |
UniProt ID | Q9HCB6 |
UniProt Comment |
|
Reactome |
|
All locus annotations are based on the sentinel SNP (rs10832169) and 35 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by |
|
Potentially regulated genes |
|
eQTL genes |
|
Trait | P | Study | Source |
---|---|---|---|
"Gene expression of SPON1 [transcript NM_006108, probe A_32_P133072] in liver" | 2×10-16 | 21637794 (PMID) | GRASP2 eQTL |
Height | 4.4×10-6 | 25282103 (PMID) | Supplemental file |
Nicotine dependence (smoking), smoking cessation (nicotine replacement therapy) | 2.2×10-5 | 18519826 (PMID) | GRASP2 nonQTL |
Bipolar disorder and schizophrenia | 2.3×10-5 | 20889312 (PMID) | GRASP2 nonQTL |
Type 1 diabetes, combined control dataset, gender differentiated | 2.6×10-5 | 17554300 (PMID) | GRASP2 nonQTL |